Handelsbanken Fonder Ab Mirati Therapeutics, Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$41.99 - $62.38 $37,791 - $56,142	-900 Reduced 7.56%	11,000 $646,000
Q3 2023 Oct 19, 2023	SELL	$27.8 - $45.35 $1.81 Million - $2.95 Million	-65,000 Reduced 84.53%	11,900 $518,000
Q2 2023 Aug 02, 2023	BUY	$36.13 - $49.49 $46,969 - $64,337	1,300 Added 1.72%	76,900 $2.78 Million
Q4 2022 Feb 07, 2023	SELL	$41.27 - $98.62 $4,127 - $9,862	-100 Reduced 0.13%	75,600 $3.43 Million
Q3 2022 Oct 27, 2022	SELL	$59.5 - $86.7 $386,750 - $563,550	-6,500 Reduced 7.91%	75,700 $5.29 Million
Q2 2022 Aug 03, 2022	BUY	$39.16 - $88.71 $1.17 Million - $2.66 Million	30,000 Added 57.47%	82,200 $5.52 Million
Q3 2021 Nov 10, 2021	BUY	$132.13 - $177.45 $1.32 Million - $1.77 Million	10,000 Added 23.7%	52,200 $9.24 Million
Q2 2021 Aug 03, 2021	SELL	$144.0 - $179.73 $5 Million - $6.24 Million	-34,700 Reduced 45.12%	42,200 $6.82 Million
Q1 2021 Apr 29, 2021	SELL	$158.92 - $221.61 $794,599 - $1.11 Million	-5,000 Reduced 6.11%	76,900 $13.2 Million
Q4 2020 Feb 11, 2021	BUY	$162.05 - $240.27 $129,640 - $192,216	800 Added 0.99%	81,900 $18 Million
Q3 2020 Nov 13, 2020	BUY	$113.26 - $167.27 $3.67 Million - $5.42 Million	32,400 Added 66.53%	81,100 $13.5 Million
Q2 2020 Aug 13, 2020	BUY	$72.01 - $120.39 $806,512 - $1.35 Million	11,200 Added 29.87%	48,700 $5.56 Million
Q1 2020 May 14, 2020	BUY	$69.78 - $116.21 $418,680 - $697,260	6,000 Added 19.05%	37,500 $2.88 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $1.77 Million - $3.22 Million	-25,000 Reduced 44.25%	31,500 $4.06 Million
Q3 2019 Oct 31, 2019	BUY	$77.91 - $109.6 $1.21 Million - $1.7 Million	15,500 Added 37.8%	56,500 $4.4 Million
Q2 2019 Jul 12, 2019	BUY	$59.49 - $104.71 $59,490 - $104,710	1,000 Added 2.5%	41,000 $4.22 Million
Q1 2019 May 10, 2019	BUY	$43.65 - $78.95 $1.75 Million - $3.16 Million	40,000 New	40,000 $2.93 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account